Cargando…

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational studies so far have lacked rigorous ascertainment adjustment and international generalisability. We aimed to determine whethe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morales, Daniel R, Conover, Mitchell M, You, Seng Chan, Pratt, Nicole, Kostka, Kristin, Duarte-Salles, Talita, Fernández-Bertolín, Sergio, Aragón, Maria, DuVall, Scott L, Lynch, Kristine, Falconer, Thomas, van Bochove, Kees, Sung, Cynthia, Matheny, Michael E, Lambert, Christophe G, Nyberg, Fredrik, Alshammari, Thamir M, Williams, Andrew E, Park, Rae Woong, Weaver, James, Sena, Anthony G, Schuemie, Martijn J, Rijnbeek, Peter R, Williams, Ross D, Lane, Jennifer C E, Prats-Uribe, Albert, Zhang, Lin, Areia, Carlos, Krumholz, Harlan M, Prieto-Alhambra, Daniel, Ryan, Patrick B, Hripcsak, George, Suchard, Marc A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834915/ https://www.ncbi.nlm.nih.gov/pubmed/33342753 http://dx.doi.org/10.1016/S2589-7500(20)30289-2

Ejemplares similares

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study
por: Morales, Daniel R., et al.
Publicado: (2020)

Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study
por: Nishimura, Akihiko, et al.
Publicado: (2021)

International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients
por: Nishimura, Akihiko, et al.
Publicado: (2022)

Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe
por: Moreno-Martos, David, et al.
Publicado: (2023)

Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study
por: Reps, Jenna M, et al.
Publicado: (2021)

Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance
por: Arshad, Faaizah, et al.
Publicado: (2023)

Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis
por: Li, Xintong, et al.
Publicado: (2021)

Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design
por: Lai, Lana YH, et al.
Publicado: (2022)

Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study
por: Burn, Edward, et al.
Publicado: (2022)

Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States
por: Burn, Edward, et al.
Publicado: (2021)

Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study
por: Duarte-Salles, Talita, et al.
Publicado: (2020)

Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
por: Williams, Ross D., et al.
Publicado: (2022)

Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom
por: Recalde, Martina, et al.
Publicado: (2021)

Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study
por: Reyes, Carlen, et al.
Publicado: (2021)

Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis
por: Tan, Eng Hooi, et al.
Publicado: (2020)

COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Vaccine Safety Surveillance Using Routinely Collected Healthcare Data—An Empirical Evaluation of Epidemiological Designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases
por: Ostropolets, Anna, et al.
Publicado: (2022)

The natural history of symptomatic COVID-19 during the first wave in Catalonia
por: Burn, Edward, et al.
Publicado: (2021)

Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States
por: Golozar, Asieh, et al.
Publicado: (2020)

Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain
por: Roel, Elena, et al.
Publicado: (2021)

Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
por: Khera, Rohan, et al.
Publicado: (2022)

Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND)
por: Schuemie, Martijn J, et al.
Publicado: (2020)

Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study
por: Schuemie, Martijn J, et al.
Publicado: (2020)

Erratum to: Large-Scale Evidence Generation and Evaluation across a Network of Databases (LEGEND): Assessing Validity Using Hypertension as a Case Study
por: Schuemie, Martijn J, et al.
Publicado: (2020)

Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study
por: Li, Xintong, et al.
Publicado: (2021)

Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
por: Burn, Edward, et al.
Publicado: (2020)

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain
por: Burn, Edward, et al.
Publicado: (2022)

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
por: Prats-Uribe, Albert, et al.
Publicado: (2021)

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
por: Li, Xintong, et al.
Publicado: (2021)

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
por: Hripcsak, George, et al.
Publicado: (2020)

Evaluating a novel approach to stimulate open science collaborations: a case series of “study-a-thon” events within the OHDSI and European IMI communities
por: Hughes, N, et al.
Publicado: (2022)

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
por: Lane, Jennifer C E, et al.
Publicado: (2020)

Body mass index and risk of COVID-19 diagnosis, hospitalisation, and death: a cohort study of 2 524 926 Catalans
por: Recalde, Martina, et al.
Publicado: (2021)

A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data
por: Khalid, Sara, et al.
Publicado: (2021)

Heterologous vaccine regimens against COVID-19
por: Duarte-Salles, Talita, et al.
Publicado: (2021)

Robust empirical calibration of p‐values using observational data
por: Schuemie, Martijn J., et al.
Publicado: (2016)

Improving reproducibility by using high-throughput observational studies with empirical calibration
por: Schuemie, Martijn J., et al.
Publicado: (2018)

Drawing Reproducible Conclusions from Observational Clinical Data with OHDSI
por: Hripcsak, George, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uprn7n8b71qnn8pkhga387qek8